Literature DB >> 28194048

Challenges and Promises of Genetic Stratification of Risk in Multiple Myeloma.

Hara Prasad Pati1, Prashant Sharma2.   

Abstract

Entities:  

Year:  2017        PMID： 28194048      PMCID： PMC5280874          DOI： 10.1007/s12288-017-0778-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  13 in total

1.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

2.  Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma.

Authors:  F M Ross; A H Ibrahim; A Vilain-Holmes; M O Winfield; L Chiecchio; R K M Protheroe; P Strike; J L Gunasekera; A Jones; C J Harrison; G J Morgan; N C P Cross
Journal:  Leukemia       Date:  2005-09       Impact factor: 11.528

Review 3.  Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications.

Authors:  Avet-Loiseau Hervé; Magrangeas Florence; Moreau Philippe; Attal Michel; Facon Thierry; Anderson Kenneth; Harousseau Jean-Luc; Munshi Nikhil; Minvielle Stéphane
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

4.  Cytoplasmic Immunoglobulin Light Chain Revelation and Interphase Fluorescence In Situ Hybridization in Myeloma.

Authors:  Sarah Moore; Jeffrey M Suttle; Mario Nicola
Journal:  Methods Mol Biol       Date:  2017

Review 5.  Smoldering multiple myeloma requiring treatment: time for a new definition?

Authors:  Angela Dispenzieri; A Keith Stewart; Asher Chanan-Khan; S Vincent Rajkumar; Robert A Kyle; Rafael Fonseca; Prashant Kapoor; P Leif Bergsagel; Arleigh McCurdy; Morie A Gertz; Martha Q Lacy; John A Lust; Stephen J Russell; Steven R Zeldenrust; Craig Reeder; Vivek Roy; Francis Buadi; David Dingli; Suzanne R Hayman; Nelson Leung; Yi Lin; Joseph Mikhael; Shaji K Kumar
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

6.  Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma.

Authors:  S V Rajkumar; V Gupta; R Fonseca; A Dispenzieri; W I Gonsalves; D Larson; R P Ketterling; J A Lust; R A Kyle; S K Kumar
Journal:  Leukemia       Date:  2013-03-21       Impact factor: 11.528

Review 7.  IMWG consensus on risk stratification in multiple myeloma.

Authors:  W J Chng; A Dispenzieri; C-S Chim; R Fonseca; H Goldschmidt; S Lentzsch; N Munshi; A Palumbo; J S Miguel; P Sonneveld; M Cavo; S Usmani; B G M Durie; H Avet-Loiseau
Journal:  Leukemia       Date:  2013-08-26       Impact factor: 11.528

8.  Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types.

Authors:  Sarah R Amend; William C Wilson; Liang Chu; Lan Lu; Pengyuan Liu; Daniel Serie; Xinming Su; Yalin Xu; Dingyan Wang; Anthony Gramolini; Xiao-Yan Wen; Julie O'Neal; Michelle Hurchla; Celine M Vachon; Graham Colditz; Ravi Vij; Katherine N Weilbaecher; Michael H Tomasson
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

9.  Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.

Authors:  A J Greenberg; S V Rajkumar; T M Therneau; P P Singh; A Dispenzieri; S K Kumar
Journal:  Leukemia       Date:  2013-09-05       Impact factor: 11.528

10.  A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma.

Authors:  N Bolli; Y Li; V Sathiaseelan; K Raine; D Jones; P Ganly; F Cocito; G Bignell; M A Chapman; A S Sperling; K C Anderson; H Avet-Loiseau; S Minvielle; P J Campbell; N C Munshi
Journal:  Blood Cancer J       Date:  2016-09-02       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.